Published Research | October 2020

All 2020 Published Papers by Month | Back to Current Published Papers

October 30, 2020

  1. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier – Neurobiology Disease
  2. Handwashing and Detergent Treatment Greatly Reduce SARS-CoV-2 Viral Load on Halloween Candy Handled by COVID-19 Patients – American Society for Microbiology

October 28, 2020

  1. Risk Factors for testing positive for SARS-CoV-2 in a national US healthcare system – Clinical Infectious Diseases
  2. Short telomeres increase the risk of severe COVID-19 – Journal of Aging
  3. Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids – Nature
  4. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 – NEJM
  5. Ferret Study Reinforces Role of Aerosols in SARS-CoV-2 Spread – The Scientist

October 27, 2020

  1. SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia – Journal of Infection
  2. Characterization of Myocardial Injury in Patients With COVID-19 – Journal of the American College of Cardiology

October 26, 2020

  1. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection – Cell
  2. COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020
    – CDC
  3. A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020 – Eurosurveillance
  4. Effectiveness of steroid treatment for SARS-CoV-2 pneumonia with COP-like reaction: a case report – Disaster Medicine and Public Health Preparedness
  5. Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19 – ACS Pharmacology & Translational Science
  6. Spike mutation D614G alters SARS-CoV-2 fitness – Nature

October 23, 2020

  1. Genetic and hormonal influence on SARS-CoV-2-infection susceptibility – Annals of Oncology
  2. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus – The Lancet
  3. Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset – European Journal of Immunology
  4. Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China – JAMA
  5. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 – Science

October 22, 2020

  1. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries – The Lancet
  2. Human coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in children – Journal of Pediatric Nursing
  3. Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature – Infection Control & Hospital Epidemiology
  4. Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19 – NEJM
  5. Prolonged SARS-CoV-2 replication in an immunocompromised patient – Journal of Infectious Diseases

October 21, 2020

  1. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases – PNAS

October 20, 2020

  1. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate – Journal of Clinical Microbiology
  2. In-flight transmission of SARS-CoV-2: a review of the attack rates and available data on the efficacy of face masks – Journal of Travel Medicine
  3. Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature – Infection Control and Hospital Epidemiology

October 19, 2020

  1. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 – CDC
  2. SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients – Brazilian Journal of Infectious Diseases
  3. The household secondary attack rate of SARS-CoV-2: A rapid review – Clinical Infectious Diseases

October 16, 2020

  1. Clinical characteristics and outcomes in elderly with coronavirus disease 2019 in Beijing, China: a retrospective cohort study – Internal Emergency Medicine
  2. SARS-CoV-2 Infection Rates in Skilled Nursing Facilities – JAMA

October 14, 2020

  1. SARS-CoV-2 immunity: review and applications to phase 3 – The Lancet
  2. Antibody-like proteins that capture and neutralize SARS-CoV-2 – Science Magazine
  3. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates – NEJM

October 13, 2020

  1. What reinfections mean for COVID-19 – The Lancet

October 12, 2020

  1. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies – Nature
  2. Overall decrease of SARS-CoV-2 viral load and reduction of clinical burden: the experience of a Northern Italy hospital – Clinical Microbiology and Infection
  3. Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019–2020 – Bioscensors and Bioelectroics
  4. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019 – PLoS One
  5. Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature – European Journal of Clinical Microbiology & Infectious Diseases
  6. An aberrant STAT pathway is central to COVID-19 – Nature / cell death & differentiation
  7. Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet

October 7, 2020

  1. Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign – Clinical Microbiology and Infection
  2. The Novel SARS-CoV-2 Pandemic: Possible Environmental Transmission, Detection, Persistence and Fate during Wastewater and Water Treatment – Science of the Total Environment

October 6, 2020

  1. Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19 – Journal of Infectious Diseases
  2. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients – Annals of Translational Neurology
  3. Risk of Cardiovascular Events After Spouse’s ICU Admission – Circulation
  4. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 – CDC

October 5, 2020

  1. Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy – International Journal of Infectious Diseases
  2. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge – Brazilian Journal of Infectious Diseases

October 2, 2020

  1. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection in the UK and US – CDC
  2. Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19 – Arteriosclerosis, Thrombosis, and Vascular Biology
  3. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- – International Journal of Cardiology

October 1, 2020

  1. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes – Cell
  2. Neurological consequences of COVID-19: what have we learned and where do we go from here? – Journal of Neuroinflammation
  3. SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: A review COVID-19, thrombosis, and ischemic stroke – Journal of Emergency Medicine
  4. Coronavirus misinformation: Quantifying Sources and Themes in the COVID-19‘ Infodemic – Cornell University
All 2020 Published Papers by Month | Back to Current Published Papers